1,543
Views
6
CrossRef citations to date
0
Altmetric
Research Article

The effect of Jiedu Huoxue decoction on rat model of experimental nonbacterial prostatitis via regulation of miRNAs

, , , , , , & show all
Pages 745-759 | Received 28 May 2019, Accepted 09 Jul 2020, Published online: 06 Aug 2020

References

  • Agarwal V, Bell GW, Nam JW, Bartel DP. 2015. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 4:e05005.
  • Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 25(1):25–29.
  • Balomenos D, Martínez-A C. 2000. Cell-cycle regulation in immunity, tolerance and autoimmunity. Cell-cycle regulation in immunity, tolerance and autoimmunity. Immunol Today. 21(11):551–555.
  • Bernardo BC, Ooi JY, Lin RC, McMullen JR. 2015. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem. 7(13):1771–1792.
  • Betel D, Wilson M, Gabow A, Marks DS, Sander C. 2008. The microRNA.org resource: targets and expression. Nucleic Acids Res. 36(Database issue):D149–D153.
  • Bhardwaj N. 2017. MicroRNAs in atopic dermatitis: a review. JTGG. 1:15–22.
  • Birkenkamp KU, Coffer PJ. 2003. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J Immunol. 171(4):1623–1629.
  • Chen Y, Chen S, Zhang J, Wang Y, Jia Z, Zhang X, Han X, Guo X, Sun X, Shao C, et al. 2018. Expression profile of microRNAs in expressed prostatic secretion of healthy men and patients with IIIA chronic prostatitis/chronic pelvic pain syndrome. Oncotarget. 9(15):12186–12200.
  • Chen F, Zhu X, Sun Z, Ma Y. 2018. Astilbin inhibits high glucose-induced inflammation and extracellular matrix accumulation by suppressing the TLR4/MyD88/NF-κB pathway in rat glomerular mesangial cells. Front Pharmacol. 9:1187.
  • Clodi M, Vila G, Geyeregger R, Riedl M, Stulnig TM, Struck J, Luger TA, Luger A. 2008. Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am J Physiol Endocrinol Metab. 295(3):E686–E691.
  • Demetriou M, Granovsky M, Quaggin S, Dennis JW. 2001. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409(6821):733–739.
  • Deng Y, Wang F, Hughes T, Yu J. 2018. FOXOs in cancer immunity: knowns and unknowns. Semin Cancer Biol. 50:53–64.
  • Dennis JW, Lau KS, Demetriou M, Nabi IR. 2009. Adaptive regulation at the cell surface by N-glycosylation. Traffic. 10(11):1569–1578.
  • Ding J, Tang Y, Tang Z, Zhang X, Wang G. 2017. A variant in the precursor of microRNA-146a is responsible for development of erectile dysfunction in patients with chronic prostatitis via targeting NOS1. Med Sci Monit. 23:929–937.
  • Dong L, Zhu J, Du H, Nong H, He X, Chen X. 2017. Astilbin from Smilax glabra Roxb. attenuates inflammatory responses in complete Freund's adjuvant-induced arthritis rats. Evid Based Complement Alternat Med. 2017:8246420.
  • Dudics S, Venkatesha SH, Moudgil KD. 2018. The micro-RNA expression profiles of autoimmune arthritis reveal novel biomarkers of the disease and therapeutic response. IJMS. 19(8):2221–2293.
  • El Bezawy R, Tinelli S, Tortoreto M, Doldi V, Zuco V, Folini M, Stucchi C, Rancati T, Valdagni R, Gandellini P, et al. 2019. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition. J Exp Clin Cancer Res. 38:51.
  • Erickson BA, Schaeffer AJ, Van Le B. 2008. Chronic prostatitis. BMJ Clin Evid. 2008:1802.
  • Foucquier J, Guedj M. 2015. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect. 3(3):e00149.
  • Geary N. 2013. Understanding synergy. Am J Physiol Endocrinol Metab. 304(3):E237–E253.
  • Haflidadóttir BS, Larne O, Martin M, Persson M, Edsjö A, Bjartell A, Ceder Y. 2013. Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1. PLoS One. 8(8):e72400.
  • Huang H, Cheng Z, Shi H, Xin W, Wang TT, Yu LL. 2011. Isolation and characterization of two flavonoids, engeletin and astilbin, from the leaves of Engelhardia roxburghiana and their potential anti-inflammatory properties. J Agric Food Chem. 59(9):4562–4569.
  • Huang J, Jiang X, Liang B. 2015. Influence of eliminating dampness and resolving blood stasis method on related immunological factors and PSA of III prostatitis. Chin Arch Tradit Chin Med. 33(10):2532–2534.
  • Ichii O, Otsuka S, Sasaki N, Namiki Y, Hashimoto Y, Kon Y. 2012. Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int. 81(3):280–292.
  • Jang SY, Chae MK, Lee JH, Lee EJ, Yoon JS. 2016. Role of miR-146a in the regulation of inflammation in an in vitro model of Graves' orbitopathy. Invest Ophthalmol Vis Sci. 57(10):4027–4034.
  • Jang TL, Schaeffer AJ. 2003. The role of cytokines in prostatitis. World J Urol. 21(2):95–99.
  • Jin BR, An HJ. 2020. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis. Aging (Albany NY). 12(3):2142–2155.
  • Joachims T. 1999. Making large-scale SVM learning practical. In: Schölkopf B, Burges CJC, Smola AJ, editors. Advances in Kernel methods - support vector learning. Cambridge (MA): MIT Press, p. 169–184.
  • Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al. 2008. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36(Database issue):D480–D484.
  • Koh JS, Ko HJ, Wang SM, Cho KJ, Kim JC, Lee SJ, Pae CU. 2014. The impact of depression and somatic symptoms on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: a preliminary study in a naturalistic treatment setting. Int J Clin Pract. 68(4):478–485.
  • Lang WH, Xia HB. 2015. Shugan Jieyu capsules combined with conventional therapy for type III B prostatitis complicated by sexual dysfunction. Nat J Androl. 21(6):545–548.
  • Li R, Wang L. 2019. Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a. Mol Med Rep. 20(6):5041–5049.
  • Li T, Wang P, Wang SC, Wang YF. 2017. Approaches mediating oxytocin regulation of the immune system. Front Immunol. 7:693.
  • Liu X, Yan Z, Yan Y. 2008. Progress in Traditional Chinese Medicine treatment of chronic non-bacterial prostatitis. J Liaoning Univ Trad Chin Med. 10(3):138–139.
  • Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method. Methods. 25(4):402–408.
  • Long MD, Singh PK, Russell JR, Llimos G, Rosario S, Rizvi A, van den Berg PR, Kirk J, Sucheston-Campbell LE, Smiraglia DJ, et al. 2019. The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression. Oncogene. 38(3):421–444.
  • Lu Y, Yao R, Yan Y, Wang Y, Hara Y, Lubet RA, You M. 2006. A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice. Cancer Res. 66(4):1956–1963.
  • Lu J, Zhang Y, Gao X, Wang L, Zhang X, Bi Z, Jie R, Xu Q. 2003. Effect of Danpu granule on pathological model of experimental chronic non-bacterial prostatitis. J Tradit Chin Med. 44(9):700–701.
  • Magni S, Buoli Comani G, Elli L, Vanessi S, Ballarini E, Nicolini G, Rusconi M, Castoldi M, Meneveri R, Muckenthaler MU, et al. 2014. miRNAs affect the expression of innate and adaptive immunity proteins in celiac disease. Am J Gastroenterol. 109(10):1662–1674.
  • McClure Mark W. 2001. Smart medicine for a healthy prostate: natural and conventional therapies for common prostate disorders. Natural therapies for BPH. New York: Avery Publishing Group, Inc. Chapter 2, Prostate enlargement: benign prostatic hyperplasia (BPH); p. 19–56.
  • Nakhjavani M, Etemadi J, Pourlak T, Mirhosaini Z, Zununi Vahed S, Abediazar S. 2019. Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis. Iran J Kidney Dis. 13(3):198–206.
  • Naponelli V, Ramazzina I, Lenzi C, Bettuzzi S, Rizzi F. 2017. Green tea catechins for prostate cancer prevention: present achievements and future challenges. Antioxidants (Basel). 6(2):26.
  • Polackwich AS, Shoskes DA. 2016. Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis. 19(2):132–138.
  • Powell JD, Pollizzi KN, Heikamp EB, Horton MR. 2012. Regulation of immune responses by mTOR. Annu Rev Immunol. 30:39–68.
  • Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA. 10(10):1507–1517.
  • Riegel B, Bruenahl CA, Ahyai S, Bingel U, Fisch M, Löwe B. 2014. Assessing psychological factors, social aspects and psychiatric co-morbidity associated with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men - a systematic review. J Psychosom Res. 77(5):333–350.
  • Rusca N, Monticelli S. 2011. miR-146a in immunity and disease. Mol Biol Int. 2011:437301.
  • Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11):2498–2504.
  • Shao YP, Xue HL, Shen BX, Ding LC, Chen ZS, Wei ZQ. 2017. Saw palmetto fruit extract improves LUTS in type IIIA prostatitis patients. Nat J Androl. 23(5):417–421.
  • Shi ZG, Sun Y, Wang KS, Jia JD, Yang J, Li YN. 2019. Effects of miR-26a/miR-146a/miR-31 on airway inflammation of asthma mice and asthma children. Eur Rev Med Pharmacol Sci. 23(12):5432–5440.
  • Song C, Chen H, Chunyu S. 2018. Expression profiles and mechanisms of microRNAs in prostate cancer. Biomark J. 4:13.
  • Suojalehto H, Toskala E, Kilpeläinen M, Majuri ML, Mitts C, Lindström I, Puustinen A, Plosila T, Sipilä J, Wolff H, et al. 2013. MicroRNA profiles in nasal mucosa of patients with allergic and nonallergic rhinitis and asthma. Int Forum Allergy Rhinol. 3(8):612–620.
  • Taganov KD, Boldin MP, Chang KJ, Baltimore D. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 103(33):12481–12486.
  • Tan B, Jia R, Wang G, Yang J. 2018. Astragaloside attenuates the progression of prostate cancer cells through endoplasmic reticulum stress pathways. Oncol Lett. 16(3):3901–3906.
  • Tao Y, Zhan S, Wang Y, Zhou G, Liang H, Chen X, Shen H. 2018. Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs. Sci Rep. 8(1):14477.
  • Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC. 2012. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 110(7):1014–1022.
  • The Gene Ontology Consortium. 2019. The gene ontology resource: 20 years and still going strong. Nucleic Acids Res. 47(D1):D330–D338.
  • Traditional Chinese Medicine Experimental Pharmacology Professional Committee, China Association of Chinese Medicine. 2018. Specifications for preparation of chronic prostatitis animal models. Chin J Exp Trad Med Formulae. 24(19):10–14.
  • Tu Y, Wu Z, Tan B, Yang A, Fang Z. 2019. Emodin: its role in prostate cancer-associated inflammation (Review). Oncol Rep. 42:1259–1271.
  • Wang P. 2017. Advances in cytokines of chronic prostatitis/chronic pelvic pain syndrome research. Int J Urol Nephrol. 37(4):596–599.
  • Wang W, Feng J, Yan Z, Han W. 2010. Clinical efficacy of Jiedu Huoxue decoction in the treatment of type IIIa prostatitis and its effect on the levels of IL-6 and IL-8 in prostatic fluid of patients. Guide China Med. 8(6):107–109.
  • Wang W, Gao J, Wang F. 2017. MiR-663a/MiR-423-5p are involved in the pathogenesis of lupus nephritis via modulating the activation of NF-κB by targeting TNIP2. Am J Transl Res. 9(8):3796–3803.
  • Wang W, Wang Z, Wu S, Chen S, Chen P. 2016. Therapeutic effect analysis of 50 cases of Type IIIa prostatitis treated with medicinal oil heat-sensitization moxibustion combined with Jiedu Huoxue decoction. Lishizhen Med Materia Medica Res. 27(8):1925–1926.
  • Wang W, Yan Z. 2006. 68 cases of chronic abacterial prostatitis treated with Jiedu Huoxue decoction. J Tradit Chin Med. 47(12):923–924.
  • Wang W, Yan Z. 2007. Observation on the therapeutic effect of Jiedu Huoxue decoction on chronic nonbacterial prostatitis. Nat J Androl. 13(3):275–276.
  • Wang Z, Yuan L, Wang Y, Yang B, Dong X, Gao Z. 2016. Efficacy and safety of Chinese herbal medicine for chronic prostatitis associated with damp-heat and blood-stasis syndromes: a meta-analysis and literature review. PPA. 10:1889–1902.
  • Wang W, Zheng J, Xiong H, Yan Z. 2012. Effect of Jiedu Huoxue decoction on TNF-α, IL-8 and IL-10 in prostate tissue homogenate of rats with chronic abacterial prostatitis. J New Chin Med. 44(12):133–134.
  • Watahiki A, Macfarlane RJ, Gleave ME, Crea F, Wang Y, Helgason CD, Chi KN. 2013. Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer. Int J Mol Sci. 14(4):7757–7770.
  • Wei W, Zhang W, Dai J. 2006. Development of a rat model for nonbacterial chronic prostatitis. Chin J Androl. 20(1):22–24.
  • Wen ZP, Hong ZM, Lin XY, Lin F, Quan L, Wang Y, Liu XL. 2010. Effect of Qianliehuoxue decoction on inflammatory factors in rat model of autoimmune prostatitis. World J Integr Tradit West Med. 5(5):396–400.
  • Xu SY, Bian RL, Chen X. 2002. Methodology of pharmacological experiment. 3rd ed. Beijing: People's Medical Publishing House.
  • Xu Y, Zhou B, Wu D, Yin Z, Luo D. 2012. Baicalin modulates microRNA expression in UVB irradiated mouse skin. J Biomed Res. 26(2):125–134.
  • Yan Z, Huang C, Huang G, Wu Y, Wang J, Yi J, Mao W, Wang W. 2019. Jiedu Huoxue decoction improves inflammation in rat type III prostatitis: the importance of the NF-κB signalling pathway. Andrologia. 51(5):e13245.
  • Yang Y, Wang JK. 2016. The functional analysis of MicroRNAs involved in NF-κB signaling. Eur Rev Med Pharmacol Sci. 20(9):1764–1774.
  • Zhang Y, Zhang H, Zhao B. 2018. Hippo signaling in the immune system. Trends Biochem Sci. 43(2):77–80.
  • Zhang K, Zeng X, Chen Y, Zhao R, Wang H, Wu J. 2017. Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats. BMC Complement Altern Med. 17(1):75.
  • Zhao Z, Zhu M. 2016. Research progress of traditional Chinese medicine treating chronic prostatitis. Chin J Hum Sex. 25(2):87–89.
  • Zhou H, Chen JX, Yang CS, Yang MQ, Deng Y, Wang H. 2014. Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer. BMC Genomics. 15(Suppl 11):S3.
  • Zhou XH, Li LD, Wu LM, Han L, Liu ZD, Yang JX, Lv YW, You CL, Zhou ZH. 2007. Increased inflammatory factors activity in model rats with experimental autoimmune prostatitis. Arch Androl. 53(2):49–52.
  • Zhu L, Liu J, Cheng G. 2014. Role of miRNAs in schistosomes and schistosomiasis. Front Cell Infect Microbiol. 4:165.